Metraipolis › archive › dc_779cd06f5a10
Primary Tumor Size and Tumor-Vessel Interface Following Capecitabine and Temozolomide for Pancreatic Neuroendocrine Tumor — Europe PMC PMID:41744875
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41744875
- DOI
- 10.3390/curroncol33020111
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-05T21:51:36.457Z
- SHA-256 of the archived text
c5bc0cea6812c062da256d3ded0f9086538b9cd7d05ec802984c72a18a2bd92f- Stable URL of this page
https://metraipolis.com/documento/dc_779cd06f5a10
How to cite
Primary Tumor Size and Tumor-Vessel Interface Following Capecitabine and Temozolomide for Pancreatic Neuroendocrine Tumor — Europe PMC PMID:41744875 — Europe PMC (en), https://europepmc.org/article/MED/41744875 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_779cd06f5a10 (Metraipolis archive dc_779cd06f5a10, sha256 c5bc0cea6812c062da256d3ded0f9086538b9cd7d05ec802984c72a18a2bd92f)
BibTeX
@misc{dc779cd06f5a10,
title = {Primary Tumor Size and Tumor-Vessel Interface Following Capecitabine and Temozolomide for Pancreatic Neuroendocrine Tumor — Europe PMC PMID:41744875},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41744875},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_779cd06f5a10; sha256 c5bc0cea6812c062da256d3ded0f9086538b9cd7d05ec802984c72a18a2bd92f},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41744875. Agents can read the archived copy with the MCP tool read_document.